two hundred twelve evaluable patients were randomly assigned to treatment with the six-drug combination , bcnu , cyclophosphamide , vinblastine , procarbazine , prednisone , and bleomycin ( bcvpp-bleo ) or with the same drugs alternating in monthly cycles with doxorubicin , dacarbazine , and bleomycin .
C0010583
cyclophosphamide
C0054326
bcvpp